MolNFT v1 · #115485 · protein + DNA
Alkylpurine DNA glycosylase alkd bound to DNA containing a 3- methyladenine analog (9-mer a)
5CLB: “Alkylpurine DNA glycosylase alkd bound to DNA containing a 3- methyladenine analog (9-mer a)”. X-ray diffraction, 2 pockets (best druggability 0.79). MolNFT v1 #115485 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5CLB
- Type
- protein + DNA
- Length
- 242 residues
- Chains
- 3
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Alkd; DNA (5'-D(*AP*AP*GP*CP*AP*(DZM)P*AP*CP*C)-3'); DNA…
- EC
- 3.2.2.-
- UniProt
- R8GWR7
- Pockets
- 2 · best druggability 0.79
Structure
x-ray diffraction · 3 distinct chains · 73% helix, 1% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Alkd (EC 3.2.2.-) | protein | 224 | 73% helix, 1% strand | R8GWR7 |
| B | DNA (5'-D(*AP*AP*GP*CP*AP*(DZM)P*AP*CP*C)-3') | dna | 9 | — | — |
| C | DNA (5'-D(*TP*GP*GP*TP*TP*TP*GP*CP*T)-3') | dna | 9 | — | — |
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 672 | 0.79 | 0.84 | 53 | empty |
| 2 | 133 | 0.44 | 0.76 | 16 | empty |
Interfaces
3 interfaces between chains.
- A–B · 497 Ų buried · 12 hydrogen bonds · protein-nucleic
- B–C · 396 Ų buried · 36 hydrogen bonds · nucleic-nucleic
- A–C · 257 Ų buried · 8 hydrogen bonds · protein-nucleic
Modifications
Observed in the structure: 1 modified (nucleotide modification).
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt R8GWR7
- Elsewhere: RCSB PDB 5CLB · PDBe 5CLB · UniProt R8GWR7
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.